147 related articles for article (PubMed ID: 15860224)
1. Analysis of the immune response induced by a single xenoantigen in vivo.
Sireci G; Dieli F; Barera A; Di Sano C; Bonanno CT; Salerno A
Immunol Lett; 2005 May; 98(2):245-52. PubMed ID: 15860224
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules.
Pajot A; Pancré V; Fazilleau N; Michel ML; Angyalosi G; Ojcius DM; Auriault C; Lemonnier FA; Lone YC
Int Immunol; 2004 Sep; 16(9):1275-82. PubMed ID: 15249541
[TBL] [Abstract][Full Text] [Related]
3. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
4. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
[TBL] [Abstract][Full Text] [Related]
5. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
Camacho RE; Wnek R; Shah K; Zaller DM; O'Reilly RJ; Collins N; Fitzgerald-Bocarsly P; Koo GC
Cell Immunol; 2004; 232(1-2):86-95. PubMed ID: 15922719
[TBL] [Abstract][Full Text] [Related]
6. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
[TBL] [Abstract][Full Text] [Related]
7. A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice.
Pajot A; Michel ML; Fazilleau N; Pancré V; Auriault C; Ojcius DM; Lemonnier FA; Lone YC
Eur J Immunol; 2004 Nov; 34(11):3060-9. PubMed ID: 15468058
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation of mycobacterial peptides to human T cell clones can be immunomodulated by adding an MHC-specific inhibitor.
Méndez-Samperio P
Cell Immunol; 1993 Apr; 148(1):1-9. PubMed ID: 8495481
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
Camacho RE; Wnek R; Fischer P; Shah K; Zaller DM; Woods A; La Monica N; Aurisicchio L; Fitzgerald-Bocarsly P; Koo GC
Exp Hematol; 2007 Aug; 35(8):1219-30. PubMed ID: 17662890
[TBL] [Abstract][Full Text] [Related]
10. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
[TBL] [Abstract][Full Text] [Related]
11. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
Yoshizawa K; Yano A
J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
[TBL] [Abstract][Full Text] [Related]
12. Expression of the human MHC, HLA-DQW6 genes alters the immune response in C57BL/6 mice.
Nishimura Y; Iwanaga T; Inamitsu T; Yanagawa Y; Yasunami M; Kimura A; Hirokawa K; Sasazuki T
J Immunol; 1990 Jul; 145(1):353-60. PubMed ID: 2358677
[TBL] [Abstract][Full Text] [Related]
13. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
[TBL] [Abstract][Full Text] [Related]
15. HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice.
Vertuani S; Triulzi C; Roos AK; Charo J; Norell H; Lemonnier F; Pisa P; Seliger B; Kiessling R
Cancer Immunol Immunother; 2009 May; 58(5):653-64. PubMed ID: 18820911
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
Olson RR; De Magistris MT; Di Tommaso A; Karr RW
J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
[TBL] [Abstract][Full Text] [Related]
17. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
[TBL] [Abstract][Full Text] [Related]
18. Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.
Zeng Y; Gao T; Zhao G; Jiang Y; Yang Y; Yu H; Kou Z; Lone Y; Sun S; Zhou Y
Hum Vaccin Immunother; 2016 Mar; 12(3):829-36. PubMed ID: 26479036
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
Zota V; Nemirovsky A; Baron R; Fisher Y; Selkoe DJ; Altmann DM; Weiner HL; Monsonego A
J Immunol; 2009 Sep; 183(5):3522-30. PubMed ID: 19675171
[TBL] [Abstract][Full Text] [Related]
20. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
